Numeta G

Valine, the active ingredient in Numeta G, is a parenteral nutrition supplement presented as a solution for intravenous use. It supports metabolic needs in patients requiring comprehensive amino acid nutrition, particularly in critical care and neonatal settings. GNH USA supplies Numeta G as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and neonatal intensive care units worldwide.

GNH USA supplies Numeta G as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and neonatal intensive care units worldwide.

Numeta G is used as a component of parenteral nutrition regimens for patients with complex metabolic demands. It provides essential amino acids to support: - Critical illness: helps maintain nitrogen balance and supports tissue repair. - Neonatal care: supplies necessary amino acids for growth in preterm infants. - Post‑surgical recovery: contributes to protein synthesis during convalescence. - Severe malnutrition: assists in rebuilding lean body mass. - Metabolic disorders: offers a controlled amino acid profile for specific inborn errors. - Long‑term home parenteral nutrition: enables outpatient amino acid supplementation.

Numeta G may be associated with infusion‑related reactions and metabolic disturbances.

Common Side Effects: - Hyperglycaemia: elevated blood glucose during infusion. - Electrolyte shifts: changes in potassium, sodium or calcium levels. - Mild fever or chills: transient temperature rise. - Local irritation: redness or discomfort at the IV site. - Nausea: occasional feeling of queasiness. - Headache: mild, transient headache.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Metabolic acidosis: significant pH imbalance. - Hyperammonemia: elevated ammonia levels in blood. - Sepsis: infection linked to catheter use. - Thrombophlebitis: vein inflammation with clot formation. - Renal impairment: worsening kidney function in susceptible patients.

Before initiating Numeta G, clinicians should assess patient-specific factors and monitor relevant parameters.

- Renal function: evaluate baseline creatinine and adjust infusion rates if impaired. - Hepatic function: monitor liver enzymes in patients with liver disease. - Electrolyte balance: check serum electrolytes prior to and during therapy. - Glycaemic control: monitor blood glucose in diabetic or hyperglycaemic patients. - Allergic history: review prior reactions to amino‑acid solutions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Numete ​     ");

"""""  "  ""  """" " """  "  "" " "  " "" " " "  "" " "  "  "" "  "" "  "  "  "  "" """ " "" " " …

Major  ");  "" " ".

"  "  "" "  "  "  "  " " "  " "  " "  " "  " "  " " 

"  " " " " " " " " "  " " "  " "  " "  " "  ");

" " " " label  "  "  " ".

" "  " "  " "  ");"